How are RAC unaware when other researchers do use Zantrene®?
Because those investigators are only performing preclinical research and have purchased non-GMP quality Zantrene from online drug suppliers like Sigma Aldrich; they aren’t obliged to inform RAC of their studies. However this is a different story with clinical trials, where GMP quality drugs are required for human use. RAC have the GMP manufacture and human use of Zantrene extensively covered by patents, and so no research outside of preclinicals can take place without their knowledge and consent.
Frequently Asked Questions, page-14
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 1400 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |